EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reduced prevalence of phage defense systems in Pseudomonas aeruginosa strains from cystic fibrosis patients

Daan F van den Berg iD, Stan J J Brouns iD

mBio · 2025

DOI: 10.1128/mbio.03548-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, 2025. Verfasst von Daan F van den Berg und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bionanoscience, Delft University of Technology, Delft, the Netherlands. Hauptthemen laut MEDLINE: Cystic Fibrosis, Pseudomonas aeruginosa, Pseudomonas Infections, Bacteriophages. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EC | European Research Council (ERC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cystic fibrosis is a genetic disorder that affects mucus clearance, particularly of the lungs. As a result, cystic fibrosis patients often experience infections from bacteria, which contribute to the disease progression. Pseudomonas aeruginosa is one of the most common opportunistic pathogens associated with cystic fibrosis. The presence of P. aeruginosa complicates the treatment due to its high antibiotic resistance. Thus, research is ongoing to treat these infections with bacterial viruses instead, known as bacteriophages. Notably, P. aeruginosa clinical strains possess a variety of phage defense mechanisms that may limit the effectiveness of phage therapy. In this study, we compared the defense system repertoire of P. aeruginosa strains isolated from cystic fibrosis patients with those from non-cystic fibrosis patients. Our findings reveal that P. aeruginosa strains isolated from cystic fibrosis patients have fewer phage defense mechanisms per strain than from non-cystic fibrosis patients, suggesting altered phage selection pressures in strains colonizing CF patient lungs. IMPORTANCE Cystic fibrosis patients often experience chronic Pseudomonas aeruginosa lung infections, which are challenging to treat with antibiotics and contribute to disease progression and eventual respiratory failure. Phage therapy is being explored as an alternative treatment strategy for these infections. However, assessing strain susceptibility to phage treatment is essential for ensuring efficacy. To address this, we investigated whether CF-associated clinical P. aeruginosa strains have a distinct phage defense repertoire compared with those isolated from other lung patients. We observed that CF-associated P. aeruginosa strains have significantly fewer phage defenses, possibly affecting the susceptibility of these strains to phage infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisPseudomonas aeruginosaPseudomonas InfectionsBacteriophagesPseudomonas PhagesHumansPhage Therapy

Stichwörter der Autor:innen

CRISPR-CasPseudomonas aeruginosaWadjetZoryacystic fibrosismucusphage defense systemsphage therapyplasmid-restrictive mechanisms

Autor:innen und Institutionen

  • Department of Bionanoscience, Delft University of Technology, Delft, the Netherlands.
  • Kavli Institute of Nanoscience, Delft, the Netherlands.

ORCID-Profile: Daan F van den Berg, Stan J J Brouns

Förderung

  • EC | European Research Council (ERC)

Zitieren

APA

van den Berg, D. F., & Brouns, S. J. J. (2025). Reduced prevalence of phage defense systems in Pseudomonas aeruginosa strains from cystic fibrosis patients. mBio. https://doi.org/10.1128/mbio.03548-24

Vancouver

van den Berg DF, Brouns SJJ. Reduced prevalence of phage defense systems in Pseudomonas aeruginosa strains from cystic fibrosis patients. mBio. 2025. doi:10.1128/mbio.03548-24

BibTeX
@article{vandenBerg2025,
  author = {van den Berg, Daan F and Brouns, Stan J J},
  title = {Reduced prevalence of phage defense systems in Pseudomonas aeruginosa strains from cystic fibrosis patients},
  journal = {mBio},
  year = {2025},
  doi = {10.1128/mbio.03548-24}
}
Kostenlos starten →